• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内 CD8(+) T/FOXP3 (+) 细胞比值是结直肠癌患者生存的预测标志物。

Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

机构信息

Department of Cancer Therapy and Research, Kyushu University, Maidashi, Higashi-Ku, Fukuoka, Japan.

出版信息

Cancer Immunol Immunother. 2010 May;59(5):653-61. doi: 10.1007/s00262-009-0781-9. Epub 2009 Nov 12.

DOI:10.1007/s00262-009-0781-9
PMID:19908042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11030791/
Abstract

The human immune system consists of a balance between immune surveillance against non-self antigens and tolerance of self-antigens. CD8(+) T cells and CD4(+) regulatory T cells (Tregs) are the main players for immune surveillance and tolerance, respectively. We examined immunohistochemically the immunological balance at the tumor site using 94 surgically resected colorectal cancer tissues. Forkhead box P3 (FOXP3)(+) cells were considered to be Tregs in the present study. The number of intratumoral FOXP3(+) cells (itFOXP3(+) cells) was positively correlated with lymph node metastases (P = 0.030). itCD8(+) T/itFOXP3(+) cell ratio negatively correlated with pathological stages (P = 0.048). Next, relationship between the number of itCD8(+) T cells or itFOXP3(+) cells and survival prognosis in 94 patients who underwent a curative resection was analyzed. Only itCD8(+) T/itFOXP3(+) cell ratio positively correlated with disease-free survival (0.023) and overall survival (P = 0.010). Multivariate analysis indicated that itCD8(+) T/itFOXP3(+) cell ratio is an independent prognostic factor (P = 0.035) of overall survival. The number of itFOXP3(+) cells positively correlated with transforming growth factor-beta TGF-beta production at the tumor site (P = 0.020). In conclusion, itCD8(+) T/itFOXP3(+) cell ratio is a predictive marker for both disease-free survival time and overall survival time in patients with colorectal cancer. Importantly, itCD8(+) T/itFOXP3(+) cell ratio may be an independent prognostic factor. And, tumor-producing TGF-beta may contribute to the increased number of itFOXP3(+) cells.

摘要

人体免疫系统由针对非自身抗原的免疫监视和自身抗原耐受之间的平衡组成。CD8(+)T 细胞和 CD4(+)调节性 T 细胞(Tregs)分别是免疫监视和耐受的主要参与者。我们使用 94 例手术切除的结直肠癌组织,通过免疫组织化学方法检查了肿瘤部位的免疫平衡。在本研究中,FOXP3(+)细胞被认为是 Tregs。肿瘤内 FOXP3(+)细胞(itFOXP3(+)细胞)的数量与淋巴结转移呈正相关(P = 0.030)。itCD8(+)T/itFOXP3(+)细胞比值与病理分期呈负相关(P = 0.048)。接下来,分析了 94 例接受根治性切除术的患者中 itCD8(+)T 细胞或 itFOXP3(+)细胞数量与生存预后的关系。只有 itCD8(+)T/itFOXP3(+)细胞比值与无病生存率(0.023)和总生存率(P = 0.010)呈正相关。多变量分析表明,itCD8(+)T/itFOXP3(+)细胞比值是总生存率的独立预后因素(P = 0.035)。肿瘤内 itFOXP3(+)细胞的数量与肿瘤部位转化生长因子-β(TGF-β)的产生呈正相关(P = 0.020)。总之,itCD8(+)T/itFOXP3(+)细胞比值是结直肠癌患者无病生存时间和总生存时间的预测标志物。重要的是,itCD8(+)T/itFOXP3(+)细胞比值可能是独立的预后因素。并且,肿瘤产生的 TGF-β可能导致 itFOXP3(+)细胞数量增加。

相似文献

1
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.肿瘤内 CD8(+) T/FOXP3 (+) 细胞比值是结直肠癌患者生存的预测标志物。
Cancer Immunol Immunother. 2010 May;59(5):653-61. doi: 10.1007/s00262-009-0781-9. Epub 2009 Nov 12.
2
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.CD4/CD8+T 细胞、树突状细胞亚群、Foxp3 和 IDO 表达是预测胃癌预后的指标。
Cancer Med. 2019 Dec;8(17):7330-7344. doi: 10.1002/cam4.2596. Epub 2019 Oct 20.
3
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.浸润性淋巴细胞、肿瘤特征与早期乳腺癌患者复发。
Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.
4
Prognostic value of intra-tumoral CD8 /FoxP3 lymphocyte ratio in patients with resected colorectal cancer liver metastasis.肿瘤内CD8/FoxP3淋巴细胞比率对已切除的结直肠癌肝转移患者的预后价值
J Surg Oncol. 2018 Jul;118(1):68-76. doi: 10.1002/jso.25091. Epub 2018 Jun 7.
5
Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer.肿瘤内 FOXP3+VEGFR2+ 调节性 T 细胞是结直肠癌患者复发和生存的预测标志物。
Clin Immunol. 2013 Jan;146(1):26-33. doi: 10.1016/j.clim.2012.10.007. Epub 2012 Nov 5.
6
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.肿瘤浸润的 FoxP3+ Tregs 和 CD8+ T 细胞影响肝癌患者的预后。
Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28.
7
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.两种 FOXP3(+)CD4(+) T 细胞亚群可明显控制结直肠癌的预后。
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.
8
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.肿瘤内浸润的 CD4+和 FOXP3+T 细胞是预测可切除结直肠癌预后的强阳性预测标志物。
Br J Cancer. 2019 Oct;121(8):659-665. doi: 10.1038/s41416-019-0559-6. Epub 2019 Sep 6.
9
An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.肿瘤浸润调节性T细胞丰度增加与胰腺导管腺癌的进展和预后相关。
PLoS One. 2014 Mar 17;9(3):e91551. doi: 10.1371/journal.pone.0091551. eCollection 2014.
10
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.调节性 T 细胞浸润预测结直肠癌肝转移切除术后的结局。
Ann Surg Oncol. 2013 Mar;20(3):946-55. doi: 10.1245/s10434-012-2668-9. Epub 2012 Sep 26.

引用本文的文献

1
High intratumoral heterogeneity in clear cell renal cell carcinoma is associated with reduced immune response and survival.透明细胞肾细胞癌中高肿瘤内异质性与免疫反应降低和生存率降低相关。
Transl Androl Urol. 2025 May 30;14(5):1190-1203. doi: 10.21037/tau-2024-741. Epub 2025 May 27.
2
Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer.人嗜T淋巴细胞病毒1型(HTLV-1)感染对结直肠癌临床病理特征及肿瘤免疫微环境的影响
Virchows Arch. 2025 Mar 20. doi: 10.1007/s00428-025-04074-w.
3
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.纳米放射增强剂NBTXR3增强了质子免疫放射疗法相对于光子免疫放射疗法所实现的卓越抗肿瘤免疫反应。
J Nanobiotechnology. 2024 Oct 1;22(1):597. doi: 10.1186/s12951-024-02855-0.
4
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants.基于 DNA 甲基化的免疫细胞比例与黑人参与者的癌症风险
Cancer Res Commun. 2024 Oct 1;4(10):2714-2723. doi: 10.1158/2767-9764.CRC-24-0257.
5
Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.肿瘤浸润淋巴细胞和 PD-L1 表达在食管鳞状细胞癌中的预后价值。
Cancer Med. 2024 Sep;13(17):e70179. doi: 10.1002/cam4.70179.
6
Inferring Characteristics of the Tumor Immune Microenvironment of Patients with HNSCC from Single-Cell Transcriptomics of Peripheral Blood.从外周血单细胞转录组学推断头颈部鳞状细胞癌患者的肿瘤免疫微环境特征。
Cancer Res Commun. 2024 Sep 1;4(9):2335-2348. doi: 10.1158/2767-9764.CRC-24-0092.
7
In situ analysis of CCR8 regulatory T cells in lung cancer: suppression of GzmB CD8 T cells and prognostic marker implications.肺癌中 CCR8 调节性 T 细胞的原位分析:抑制 GzmB CD8 T 细胞和预后标志物的意义。
BMC Cancer. 2024 May 23;24(1):627. doi: 10.1186/s12885-024-12363-x.
8
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants.黑人参与者中DNA甲基化衍生的免疫细胞比例与癌症风险,包括肺癌风险
medRxiv. 2024 May 9:2024.05.09.24307118. doi: 10.1101/2024.05.09.24307118.
9
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.瘤周给予免疫调节抗体三联疗法可抑制皮肤肿瘤生长而无全身毒性。
J Immunother Cancer. 2024 Jan 31;12(1):e007960. doi: 10.1136/jitc-2023-007960.
10
Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.程序性细胞死亡配体表达在小肠腺癌中的临床意义取决于肿瘤微环境。
World J Gastroenterol. 2023 Oct 28;29(40):5566-5581. doi: 10.3748/wjg.v29.i40.5566.

本文引用的文献

1
Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.支柱文章:转录因子Foxp3对调节性T细胞发育的控制。《科学》2003年。299卷:1057 - 1061页。
J Immunol. 2017 Feb 1;198(3):981-985.
2
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.调节性T细胞与细胞毒性T细胞在肿瘤内的平衡与肝细胞癌切除术后的预后相关。
J Clin Oncol. 2007 Jun 20;25(18):2586-93. doi: 10.1200/JCO.2006.09.4565.
3
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.调节性T细胞增多与肝细胞癌患者的CD8 T细胞损伤及生存率低相关。
Gastroenterology. 2007 Jun;132(7):2328-39. doi: 10.1053/j.gastro.2007.03.102. Epub 2007 Apr 14.
4
New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.T细胞命运的新转折:转化生长因子-β和活化T细胞核因子对T细胞活化及免疫耐受的调控
Curr Opin Immunol. 2007 Jun;19(3):287-93. doi: 10.1016/j.coi.2007.04.014. Epub 2007 Apr 12.
5
Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.结直肠癌患者外周血中调节性T细胞和肿瘤浸润淋巴细胞的频率增加。
Cancer Immun. 2007 Mar 28;7:7.
6
The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery.外周记忆性与调节性CD4+ T细胞的动态协同进化
Nat Rev Immunol. 2007 Mar;7(3):231-7. doi: 10.1038/nri2037.
7
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer.人结直肠癌中FOXP3 +调节性T细胞的原位分析
J Transl Med. 2006 Dec 13;4:52. doi: 10.1186/1479-5876-4-52.
8
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.调节性T细胞的定量分析有助于识别高危乳腺癌患者以及有晚期复发风险的患者。
J Clin Oncol. 2006 Dec 1;24(34):5373-80. doi: 10.1200/JCO.2006.05.9584.
9
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.人类结肠直肠癌肿瘤内免疫细胞的类型、密度和位置可预测临床结果。
Science. 2006 Sep 29;313(5795):1960-4. doi: 10.1126/science.1129139.
10
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.FOXP3+调节性T细胞的患病率在胰腺导管腺癌及其癌前病变进展过程中升高。
Clin Cancer Res. 2006 Sep 15;12(18):5423-34. doi: 10.1158/1078-0432.CCR-06-0369.